Gwo XI Stem Cell Applied Technology Co., Ltd.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 28, 2027The maintenance fee for Method for synthesizing artepillin C and intermediate compound thereof (US 11,739,044) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,415,149 | Hepatic progenitor cells and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,518,251 | Method for enhancing therapeutic effect of stem cells on autoimmune diseases, cardiovascular diseases, and/or hematological diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 9,533,012 | Method for enhancing therapeutic effect of stem cells In force · From the USPTO record | In force | From the USPTO record | |
| US 9,523,081 | Method for enhancing therapeutic effect of stem cells on autoimmune diseases, cardiovascular diseases, and/or hematological diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 9,517,998 | Device Method of Making, Separating, and Purifying Artepillin C in Propolis In force · High confidence | In force | High confidence | |
| US 10,214,719 | Method of culturing Antrodia cinnamomea with high triterpenoids In force · From the USPTO record | In force | From the USPTO record | |
| US 11,739,044 | Method for synthesizing artepillin C and intermediate compound thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,195,754 | Cell Differentiation Medium Composition, High Secretion Insulin-Producing Cells and Preparation Method Thereof In force · High confidence | In force | High confidence | |
| US 12,310,990 | Method for treating arthritis by using stem cell preparation and method for preparing stem cell preparation In force · From the USPTO record | In force | From the USPTO record | |
| US 12,594,304 | Method for Treating Liver Cirrhosis by Using Composition Comprising Mesenchymal Stem Cell, Extracellular Vesicle Produced by Mesenchymal Stem Cell, and Growth Factor In force · High confidence | In force | High confidence |
Also on record, not counted in the 12: 2 patents in force now held by others · 4 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 pending · 7 abandoned · 9 no status recorded